The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus
Abstract Background Guidelines classify sacubitril/valsartan as a significant part of medical treatment of heart failure with reduced ejection fraction (HFrEF). Data have shown that the HbA1c levels in patients with diabetes mellitus could be impacted by sacubitril/valsartan. A possible positive eff...
| Auteurs principaux: | , , , , , , , , |
|---|---|
| Format: | Article |
| Langue: | English |
| Publié: |
Wiley
2023-04-01
|
| Collection: | ESC Heart Failure |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1002/ehf2.14239 |